Quotient Limited to Participate in the 2016 Evercore ISI MedTools Conference
November 23 2016 - 4:05PM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics
company, today announced that the Company’s senior management team,
including Chairman and Chief Executive Officer, Paul Cowan, will
participate in the Evercore ISI MedTools Conference in Boston, MA
on Wednesday, November 30, 2016.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to
reducing healthcare costs and improving patient care through the
provision of innovative tests within established markets. With an
initial focus on blood grouping and serological disease screening,
Quotient is developing its proprietary MosaiQTM technology platform
to offer a breadth of tests that is unmatched by existing
commercially available transfusion diagnostic instrument platforms.
The company's operations are based in Edinburgh, Scotland; Eysins,
Switzerland and Newtown, Pennsylvania.
INVESTORS: Paul Cowan, Chairman & Chief Executive Officer — CEO@quotientbd.com; 215-497-7006
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Sep 2023 to Sep 2024